CSIMarket
 


Scynexis Inc   (SCYX)
Other Ticker:  
 

Cumulative Scynexis Inc 's Quick Ratio for Trailing Twelve Months Period

SCYX's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

SCYX Quick Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Growth 19.97 % 2.18 % 250.34 % 27.98 % 5.86 %
Y / Y Cash & cash equivalent Growth -8.34 % -27.93 % -42.42 % -29.65 % -4.01 %
Quick Ratio for Trailing Twelve Months Period 3.16 3.34 3.71 6.38 7.36
Total Ranking # 725 # 759 # 766 # 568 # 515
Seq. Current Liabilities Growth 3.91 % -64.37 % 161.58 % 23.87 % -11.5 %
Seq. Cash & cash equivalent Growth 2.96 % 56.04 % -25.42 % -23.51 % -19.04 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Due to rise in Current Liabilities in the III. Quarter to $17 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 3.16 below Scynexis Inc average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 189 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Scynexis Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about SCYX
Quick Ratio SCYX in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 190
Sector # 320
S&P 500 # 445


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
13.1 6.31 3.14
(Jun 30 2017)   (Sep 30 2023)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Aadi Bioscience Inc   8.68 
Phathom Pharmaceuticals Inc   8.61 
Dyne Therapeutics Inc   8.58 
Oragenics Inc   8.58 
Tff Pharmaceuticals Inc   8.47 
Forte Biosciences Inc   8.41 
Matinas Biopharma Holdings Inc   8.39 
Longboard Pharmaceuticals Inc   8.37 
Chinook Therapeutics Inc   8.29 
Pds Biotechnology Corp  8.21 
Satsuma Pharmaceuticals Inc   8.08 
Processa Pharmaceuticals Inc   8.05 
Clearside Biomedical Inc   8.02 
Shattuck Labs Inc   7.94 
Context Therapeutics Inc   7.89 
Painreform Ltd  7.80 
Immuron Limited  7.73 
Marinus Pharmaceuticals Inc   7.70 
Aclaris Therapeutics Inc   7.68 
Enlivex Therapeutics Ltd   7.60 
Lexicon Pharmaceuticals Inc   7.50 
Liquidia Corporation  7.43 
Capricor Therapeutics inc   7.43 
Pyxis Oncology Inc   7.40 
Aeterna Zentaris Inc   7.39 
Abcellera Biologics Inc   7.36 
Pulmatrix Inc   7.33 
Dermata Therapeutics Inc   7.30 
Glycomimetics Inc   7.22 
Rhythm Pharmaceuticals inc   7.21 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com